Using patient feedback to improve discharge planning after cancer surgery
Official title: Integrating Electronic Patient-Reported Outcomes into Discharge Planning
Funded at Sloan-Kettering Inst Can Research · NIH-10886331 · Data updated 2026-11-12
This study is looking to make the process of leaving the hospital after cancer surgery smoother and more personalized by using a tool that helps gather your thoughts on how ready you feel to go home, so everyone involved can be on the same page and ensure you have the best experience possible.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $210,014 |
| NIH project number | 1K08CA283306-01A1 |
| Project ID | NIH-10886331 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients scheduled for elective cancer surgeries who can provide feedback on their discharge readiness.
✕Less likely to help
Patients who are not undergoing elective cancer surgeries or those who are unable to provide feedback due to medical or cognitive limitations may not benefit from this research.
What this research studies
This research aims to enhance the discharge planning process for patients undergoing cancer surgery by integrating electronic patient-reported outcomes (PROs) into the clinical workflow. By utilizing a tool called 'Goals to Discharge' (G2D), the study seeks to gather patient input on their readiness for discharge and other relevant factors, which can help align expectations between patients, caregivers, and healthcare providers. The goal is to create a more personalized discharge pathway that reduces unnecessary hospital stays and improves overall patient satisfaction. The effectiveness of this approach will be evaluated through a cluster randomized trial.
Why it matters
Potential benefit: If successful, this research could lead to shorter hospital stays and improved patient satisfaction for those undergoing cancer surgery.
How similar studies have gone: Previous research has shown that integrating patient-reported outcomes into clinical care can improve communication and patient satisfaction, suggesting a promising avenue for this approach.
Where this research is happening
-
Sloan-Kettering Inst Can Research
New York, United States Active
Researchers
- Principal investigator: Cracchiolo, Jennifer R — Sloan-Kettering Inst Can Research
- Study coordinator: Cracchiolo, Jennifer R
Related research
Other NIH-funded projects on the same topics.
-
Understand how skeletal muscle nuclei specialize and arrange themselves for proper muscle function
A study to uncover how the hundreds of nuclei in skeletal muscle fibers acquire different roles and positions to keep muscles strong and healthy.
-
Genomic profiling and outcomes of cancers in World Trade Center-exposed survivors and responders
This project looks at the genetic makeup and real-world cancer outcomes in people exposed to the World Trade Center disaster to understand how their cancers behave and respond to treatments.
-
Meaning-Centered Psychotherapy for Mexican Patients with Advanced Cancer
A cancer center in Mexico will test a culturally adapted therapy to help Mexican patients with advanced cancer find meaning, peace, and purpose at the end of life.
-
High-specificity genome-scale cell-surface proteomics to find tumor targets
A cancer research project is trying to map all the proteins on the surface of ultra-rare sarcoma cells to find safe, targeted ways to treat them.
-
Priorities for testing and choosing combination therapies in rhabdoid tumors to guide clinical trials
A coordinated, multi-site effort will rigorously test promising drug combinations in rhabdoid tumors to identify the most promising options for future patient trials.
-
ecDNA in Cancer: Understanding and targeting circular DNA that drives tumor growth
A cancer-focused project to understand how extrachromosomal DNA helps tumors grow and resist treatment, and to develop new ways to target these mechanisms.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.